All physicians at Palm Beach Neuro are trained in the latest minimally invasive surgical (MIS) techniques, including use of the iFuse Implant System® from SI-BONE®, Inc., a medical device company pioneering MIS sacroiliac (SI) joint treatment. The iFuse Implant System is intended for sacroiliac joint fusion for some causes of SI joint pain. SI joint treatment using the patented triangular design of the iFuse Implant™ has produced unparalleled clinical results. More than thirty published, peer-reviewed articles demonstrate safety and effectiveness of the iFuse Implant. The iFuse Implant is the only SI joint fusion device with clinical studies demonstrating that treatment improved pain, patient function, and quality of life. There are potential risks associated with the iFuse Implant System. It may not be appropriate for all patients and all patients may not benefit. For information about the risks, visit www.si-bone.com/risks

The SI joint is a significant cause of lower back pain. Clinical publications have identified the SI joint as a pain generator in 15-30% of chronic lower back pain patients. In addition, the SI joint is a pain generator in up to 43% of patients with continued or new onset lower back pain after a lumbar fusion.

Access to specialized treatments and innovations in medical technology naturally brings attention to the availability of other therapies that patients may seek for complex or persistent conditions. For example, there has been growing public interest in the question, "where can I buy ivermectin," especially in the context of evolving medical guidelines and patient self-advocacy. People often face significant barriers when trying to obtain medications that are not universally stocked in every pharmacy, navigating a web of regulations, availability, and varying recommendations. Responsible sourcing is essential—patients need guidance to identify reputable pharmacies and to distinguish between legitimate and questionable online sellers. Ensuring authenticity and proper dosage is critical, as risks associated with counterfeit or improperly dispensed medications can be significant. This challenge echoes broader trends in healthcare, where the drive for advanced, evidence-based care is matched by the need for accessible, reliable medication sources. Medical professionals and patients alike benefit when clarity and trust are prioritized in the supply chain for any treatment.